PMHNP Scope of Practice for Depression in California

If you’re a psychiatrist or PMHNP treating depression, you’ve probably asked yourself: Can I legally prescribe antidepressants—or controlled medications for anxiety, ADHD, or insomnia—via telehealth?

The short answer in 2026: Yes, but the rules depend on your state, your specialty, and the medication.

Let’s cut through the confusion. Federal telehealth flexibilities for controlled substances are extended through December 31, 2026, meaning you can prescribe Schedule II–V medications via video visits without an initial in-person exam. Most depression medications (SSRIs, SNRIs, bupropion) aren’t controlled substances, so they’ve never been restricted. But what about when your depressed patient also needs treatment for co-occurring ADHD or anxiety? That’s where the nuances matter.

This guide walks through the current federal DEA rules, state-by-state telehealth prescribing laws, and scope-of-practice differences between psychiatrists and PMHNPs—so you know exactly what you can do in your state, right now.

Federal Rules: DEA Telehealth Flexibilities Through 2026

The Ryan Haight Act—and Why It’s (Temporarily) on Hold

Under normal circumstances, the Ryan Haight Online Pharmacy Consumer Protection Act of 2008 requires providers to conduct at least one in-person medical evaluation before prescribing controlled substances via telemedicine. This federal law was designed to prevent online ‘pill mills.’

But during COVID-19, that requirement was suspended. The DEA and HHS have now extended those telehealth flexibilities four times—most recently through December 31, 2026. That means:

• You can prescribe Schedule II–V controlled substances (Adderall, Xanax, Ambien, etc.) to new patients via telehealth without ever seeing them in person, as long as you meet standard-of-care requirements.
• This applies nationwide for psychiatrists, PMHNPs, and other prescribers with DEA registrations.
• Non-controlled depression medications (SSRIs, SNRIs, TCAs, etc.) have never been subject to the Ryan Haight Act and can be prescribed via telehealth with no federal restrictions.

What happens after 2026? The DEA is developing permanent rules. In January 2025, they proposed a Special Registration for Telemedicine that would allow certain specialists—including board-certified psychiatrists—to prescribe Schedule II medications via telehealth indefinitely, without in-person visits. PMHNPs may be able to prescribe Schedule III–V under a separate telemedicine registration. These rules are still under public comment, but the direction is clear: telepsychiatry prescribing is here to stay.

The Bottom Line for Depression Providers

• Antidepressants (SSRIs, SNRIs, Wellbutrin, etc.): No federal restrictions. Prescribe via telehealth as you would in person.
• Adjunct controlled meds (benzodiazepines, stimulants, sleep aids): Allowed via telehealth through 2026 under current DEA extensions. After 2026, likely to require a special DEA telemedicine registration (especially for Schedule IIs).
• Buprenorphine for opioid use disorder: The DEA finalized a rule allowing up to 180 days of telehealth prescribing without in-person evaluation—relevant if you treat depression with co-occurring OUD.

Key takeaway: Federal law is not your barrier right now. The complexity comes from state laws and scope-of-practice differences between psychiatrists and PMHNPs.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs. PMHNPs: Who Can Do What?

Psychiatrists (MD/DO)

Psychiatrists have the broadest scope for treating depression via telehealth:

• Full prescriptive authority for all medications (controlled and non-controlled) in all 50 states.
• No supervision requirements. You can open your own telehealth practice or join a platform like Klarity and see patients independently.
• Schedule II authority. Under current federal rules, you can prescribe stimulants (Adderall, Ritalin) or other Schedule IIs via telehealth for psychiatric conditions. After 2026, the DEA proposes psychiatrists will be eligible for an Advanced Telemedicine Prescribing Registration to continue this.

The only requirements: a valid medical license in the patient’s state, a DEA registration, and compliance with standard-of-care obligations (documentation, informed consent, PDMP checks, etc.).

Psychiatric Mental Health Nurse Practitioners (PMHNPs)

PMHNPs are fully trained to diagnose and manage depression, but state law determines whether you can practice independently:

Full Practice Authority (FPA) States:

In these states, experienced PMHNPs can evaluate, diagnose, and prescribe medications (including controlled substances) without physician oversight:

• California: After 3+ years of practice, you can obtain ‘104 NP’ status under AB 890 and practice independently statewide (effective January 2024).
• New York: After 3,600 hours of practice, you can practice without a collaborative agreement (law made permanent in 2022).
• Illinois: After 4,000 hours of practice plus additional education, you can apply for Full Practice Authority and prescribe all medications independently.

Restricted Practice States:

In these states, PMHNPs must have a collaborative agreement or supervisory arrangement with a physician:

• Texas: Requires a written Prescriptive Authority Agreement with a physician who must be available for monthly consultation. No independent practice for NPs.
• Florida: Psychiatric NPs are explicitly excluded from the state’s ‘autonomous APRN’ category and must practice under a protocol with a supervising physician.
• Pennsylvania: Requires a collaborative agreement with a physician. Ongoing legislative efforts to grant FPA have not yet passed.

Controlled Substance Prescribing:

Even in restricted states, PMHNPs can typically prescribe controlled substances if they have:

1. A collaborative agreement that includes prescriptive authority.
2. Their own state controlled substance license and DEA registration.
3. Compliance with state-specific limits (e.g., some states restrict NPs from prescribing Schedule II drugs in outpatient settings).

The Practical Difference:

If you’re a PMHNP in California, New York, or Illinois with FPA, you can join a platform like Klarity and manage depression patients end-to-end with no physician involvement. If you’re in Texas, Florida, or Pennsylvania, you’ll need a collaborating physician on record—but the day-to-day clinical work (video visits, prescribing SSRIs, managing anxiety meds) is the same.

State-by-State Telehealth Prescribing Laws

Federal law sets the floor, but states can add requirements. Here’s what you need to know in the major markets:

California

Telehealth Prescribing: No state-level in-person exam requirement. Telehealth encounters are held to the same standard of care as in-person. You can prescribe controlled substances via telehealth (consistent with federal DEA rules).

NP Independence: AB 890 allows qualified PMHNPs to practice independently as of 2024. No physician supervision required after 3+ years of experience.

Licensure: You must hold a California medical license (psychiatrist) or RN license with APRN certification (PMHNP). California is not in the Interstate Medical Licensure Compact—out-of-state providers need a full CA license to treat CA patients.

Key Consideration: California has strong telehealth parity laws, so insurers (including Medi-Cal) must cover tele-mental health services. High patient demand, especially in inland and northern regions.

Texas

Telehealth Prescribing: A valid physician-patient relationship can be established via audio-visual telemedicine (Texas Occupations Code §111.005). Telephone-only is generally insufficient for new patients.

Controlled Substances: Texas bans telemedicine prescribing of controlled substances for chronic pain management unless the patient has been seen in person or via video within 90 days. This does not affect psychiatric prescribing—you can prescribe stimulants for ADHD or benzodiazepines for anxiety via telehealth after a video evaluation.

NP Scope: All APRNs in Texas require a Prescriptive Authority Agreement with a physician. No independent practice. The physician must be available for monthly consultation.

Licensure: Must hold a full Texas license (TX is an IMLC state for physicians, which simplifies multi-state licensing).

Key Consideration: 246 of Texas’s 254 counties are mental health shortage areas. Huge telehealth demand, but you’ll need to navigate NP supervision rules and ensure video (not just audio) for initial visits.

Florida

Telehealth Prescribing: Florida Statute §456.47 allows out-of-state providers to register to provide telehealth services in Florida without a full license (must renew every 2 years).

Controlled Substances: Florida prohibits telehealth prescribing of Schedule II controlled substances EXCEPT for:

• Psychiatric disorders
• Inpatient hospital care
• Hospice care
• Nursing home residents

This means psychiatrists can prescribe Adderall, Ritalin, or other Schedule IIs via telehealth for depression, ADHD, or anxiety—these fall under ‘psychiatric disorder’ treatment.

NP Scope: Florida’s 2020 NP autonomy law explicitly excluded psychiatric NPs. PMHNPs must practice under a protocol agreement with a supervising physician.

Licensure: Either a full FL license or an Out-of-State Telehealth Registration. Florida is an IMLC member for physicians.

Key Consideration: Florida’s psychiatric disorder exception makes it one of the most telehealth-friendly states for telepsychiatry. Large patient base, but PMHNPs need a supervising psychiatrist on record.

New York

Telehealth Prescribing: No state-level in-person exam requirement. Telehealth (video, phone, or other tech) is allowed for evaluation and prescribing. New York explicitly allowed audio-only telehealth for mental health during COVID and has extended these provisions.

NP Independence: Experienced NPs (>3,600 hours) can practice without a written collaborative agreement as of 2022. No physician supervision required after meeting the threshold.

Licensure: Must hold a NY medical license (psychiatrist) or NY RN license with APRN certification (PMHNP). NY is not in the IMLC or APRN compact.

Key Consideration: New York has strong telehealth parity laws and actively encourages tele-mental health to serve upstate communities. PMHNPs with 3,600+ hours can practice fully independently.

Pennsylvania

Telehealth Prescribing: No permanent telehealth statute, but the PA Department of State allows telehealth ‘within scope of practice as long as it meets standard of care.’ No state-level prohibition on prescribing controlled substances via telehealth—PA defers to federal DEA rules.

NP Scope: No full practice authority. PMHNPs must have a collaborative agreement with a physician.

Licensure: Must hold a PA license. PA is an IMLC member for physicians (joined in 2021).

E-Prescribing: Pennsylvania mandates electronic prescribing for controlled substances (Schedule II–V) with limited exceptions.

Key Consideration: Rural Pennsylvania has severe psychiatrist shortages. Telehealth is widely used, but lack of a comprehensive state telehealth law means providers should document patient consent and follow standard care practices carefully.

Illinois

Telehealth Prescribing: Illinois passed a Telehealth Expansion Act in 2021 requiring insurance parity and protecting the right to use telehealth. No in-person exam mandate—telehealth encounters meet standard of care for prescribing.

NP Independence: Full Practice Authority (FPA) available after ≥4,000 hours of clinical practice under collaboration + 250 hours of additional education. PMHNPs with FPA can prescribe all medications independently, including controlled substances.

Controlled Substances: APRNs with FPA must have a physician consultation process for managing chronic high-dose opioids, but this doesn’t typically affect routine psychiatric prescribing.

Licensure: Must hold an IL license. IL is an IMLC member for physicians.

Key Consideration: Illinois has a supportive regulatory environment for telehealth. PMHNPs with FPA can run fully independent practices. High demand in rural downstate areas.

State Comparison Table: Telehealth & Scope of Practice

The Economics of Building a Telehealth Depression Practice

Let’s talk about the real reason you’re reading this: Can you build a sustainable, profitable practice treating depression via telehealth?

The DIY Marketing Reality

Most providers assume they can attract patients cheaply through ‘organic’ channels—SEO, Google Ads, directory listings. The reality:

• SEO takes 6–12 months of consistent investment (content, backlinks, technical optimization) before generating meaningful patient flow. Most solo providers don’t have the expertise or patience.
• Google Ads for mental health keywords cost $15–40+ per click, and most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200–400+ when you factor in testing, optimization, and no-shows.
• Directory listings (Psychology Today, Zocdoc) charge monthly fees and you compete with hundreds of other providers on the same page. Zocdoc charges $35–100+ per booking, but total monthly cost including subscription adds up—and there’s no guarantee of patient volume.
• Agency/consultant fees for managing ads or SEO typically run $2,000–5,000/month, plus ad spend.

When you add it all up—agency fees, ad spend, staff time to handle and qualify leads, no-show rates from cold leads—acquiring a qualified psychiatric patient through DIY marketing realistically costs $200–500+ per patient, and that’s after months of investment with no results.

The Platform Alternative

Platforms like Klarity Health use a pay-per-appointment model: you pay a standard listing fee per new patient lead, and that’s it. No upfront marketing spend. No monthly subscription fees. No wasted ad spend on clicks that don’t convert.

The value proposition:

• Pre-qualified patients already matched to your specialty and availability—you’re not sifting through inquiries or chasing leads.
• Built-in telehealth infrastructure—no separate platform costs, no IT headaches.
• Both insurance and cash-pay patient flow—diversified revenue streams.
• You control your schedule—only pay when you see patients. Guaranteed ROI vs. gambling on marketing channels.

The math: Instead of spending $3,000–5,000/month on marketing with uncertain results, you pay only when a qualified patient books with you. For most providers—especially those starting out or scaling—that removes the risk entirely.

DIY marketing can eventually be cost-effective if you have the budget, expertise, and patience. But for providers who want to focus on clinical work (not becoming a marketing agency), a platform that handles patient acquisition is the smart economic choice.

Key Compliance and Practice Considerations

1. Licensure

You must be licensed (or hold a valid telehealth registration) in the patient’s state. Interstate Medical Licensure Compact (IMLC) helps physicians get licenses in multiple states more easily. APRNs should check if their state is in the APRN Compact (limited adoption as of 2025).

2. DEA Registration

You need a DEA registration in each state where you prescribe controlled substances. Some states allow a single DEA number to cover telehealth prescribing across state lines, but check your specific states.

3. PDMP Checks

Most states require checking the state Prescription Drug Monitoring Program before prescribing controlled substances. This applies to telehealth just as it does in-person.

4. E-Prescribing

Many states mandate electronic prescribing for controlled substances (PA, IL, NY, and others). Make sure your telehealth platform integrates with EPCS-compliant e-prescribing software.

5. Informed Consent

Document patient consent for telehealth services. Some states (e.g., Illinois) explicitly require written acknowledgment that the patient agrees to telehealth.

6. Standard of Care

Telehealth encounters must meet the same standard of care as in-person. For depression management, that typically means:

• Thorough psychiatric history and mental status exam
• Suicide risk assessment
• Documentation of diagnosis and treatment plan
• Emergency protocols (knowing how to activate local emergency services if a patient is in crisis)

7. Collaborative Agreements (for PMHNPs in Restricted States)

If you’re a PMHNP in Texas, Florida, or Pennsylvania, you’ll need a signed collaborative agreement with a physician. The physician doesn’t need to be on your video calls, but they must be available for consultation and periodic chart review.

FAQ: Telehealth Depression Prescribing

Q: Can I prescribe Lexapro or Zoloft to a new patient I’ve never met in person?

A: Yes. SSRIs and other non-controlled antidepressants are not subject to the Ryan Haight Act. As long as you conduct a proper telehealth evaluation (video visit, mental status exam, suicide screening, etc.), you can prescribe antidepressants without an in-person visit. This has always been legal—COVID didn’t change it.

Q: What about Xanax or Ativan for a patient with depression and anxiety?

A: Under current federal rules (extended through December 31, 2026), you can prescribe Schedule IV benzodiazepines via telehealth to a new patient without an in-person visit, as long as you conduct a proper evaluation. After 2026, you’ll likely need a DEA telemedicine registration to continue this practice.

Check your state law—most states defer to federal rules, but a few have specific requirements.

Q: Can I prescribe Adderall or Ritalin via telehealth for a depressed patient with co-occurring ADHD?

A: Yes, under current federal rules. Schedule II stimulants can be prescribed via telehealth through 2026 under the DEA’s COVID-era flexibilities.

State exceptions:

• Florida: Explicitly allows Schedule II prescribing via telehealth for psychiatric disorders.
• Other states: Generally no additional restrictions beyond federal law.

After 2026, psychiatrists will likely be eligible for an Advanced Telemedicine Prescribing Registration to continue prescribing Schedule IIs via telehealth.

Q: I’m a PMHNP in Texas. Can I practice independently via telehealth?

A: No. Texas requires all APRNs to have a Prescriptive Authority Agreement with a physician. The physician doesn’t need to be on your video calls, but they must be available for monthly consultation and chart review.

If you join a platform like Klarity, you’ll need to identify a collaborating physician as part of your onboarding.

Q: I’m a PMHNP in California. Can I practice independently via telehealth?

A: Yes, if you qualify under AB 890. After 3+ years of practice, you can obtain ‘104 NP’ status and practice independently statewide, including via telehealth. No physician supervision required.

Q: Do I need a separate license to practice telehealth across state lines?

A: Generally, yes. You need a medical license (or APRN license) in the patient’s state.

Exceptions:

• Florida allows out-of-state providers to register for telehealth without a full license (must renew every 2 years).
• Interstate Medical Licensure Compact (IMLC) simplifies multi-state licensing for physicians in member states (TX, PA, IL, FL; not CA or NY).
• APRN Compact is being adopted but has limited participation as of 2025.

Q: What happens after the DEA’s telehealth flexibilities expire in 2026?

A: The DEA is developing permanent rules. The proposed framework includes:

1. A Special Registration for Telemedicine allowing providers to prescribe Schedule III–V controlled substances via telehealth without in-person visits.
2. An Advanced Telemedicine Prescribing Registration for board-certified psychiatrists (and certain other specialists) to prescribe Schedule II medications via telehealth.

These rules are under public comment, but the direction is clear: telepsychiatry prescribing will continue, with some additional registration and reporting requirements.

Q: Are there any psychiatric medications I can’t prescribe via telehealth?

A: The only medication-specific restriction is esketamine (Spravato) for treatment-resistant depression. The FDA requires esketamine to be administered under supervision in a certified medical setting due to REMS program requirements—patients can’t take it home.

You can conduct the psychiatric evaluation via telehealth, then arrange for the patient to receive esketamine at a local REMS-certified clinic.

How to Get Started

If you’re a psychiatrist or PMHNP ready to build a telehealth depression practice, here’s what you need:

1. Confirm your state’s rules. Check whether your state allows independent practice (for PMHNPs) and whether there are any telehealth-specific prescribing restrictions.

2. Get licensed in your target states. If you want to treat patients in multiple states, consider the IMLC (for physicians) or work with a licensing service to streamline the process.

3. Obtain DEA registrations. You’ll need a DEA number in each state where you prescribe controlled substances.

4. Set up e-prescribing. Make sure your platform supports EPCS-compliant e-prescribing for controlled substances (required in many states).

5. Choose your patient acquisition strategy. DIY marketing (SEO, Google Ads, directories) can work, but it’s expensive, time-consuming, and uncertain. Platforms like Klarity eliminate upfront marketing costs and deliver pre-qualified patients—you only pay when they book.

6. Document everything. Telehealth encounters must meet the same standard of care as in-person. Use templates for informed consent, suicide risk assessments, and treatment plans.

Why Klarity Health?

Klarity Health connects psychiatrists and PMHNPs with patients seeking depression treatment via telehealth. Here’s why providers choose Klarity:

• No upfront marketing spend. We handle patient acquisition—you pay a standard listing fee per new patient lead, and that’s it.
• Pre-qualified patients. Patients are matched to your specialty, availability, and insurance acceptance before they book.
• Built-in telehealth platform. No need for separate video software, EHR integrations, or IT support.
• Both insurance and cash-pay patients. Diversify your revenue and reach patients who need care.
• You control your schedule. See as many or as few patients as you want. No minimums, no quotas.

For PMHNPs in restricted states: If you’re in Texas, Florida, or Pennsylvania, we can help you connect with collaborating physicians to meet state requirements.

For psychiatrists and independent PMHNPs: You’re free to practice autonomously on our platform—no supervision needed.

The Bottom Line

Treating depression via telehealth in 2026 is legally straightforward—as long as you understand your state’s rules and stay current on federal DEA regulations.

• Antidepressants: No restrictions. Prescribe via telehealth freely.
• Adjunct controlled meds (anxiety, sleep, ADHD): Allowed through 2026 under federal flexibilities. After 2026, likely to require a DEA telemedicine registration.
• Scope of practice: Psychiatrists have full authority in all states. PMHNPs have full authority in some states (CA, NY, IL) and require physician collaboration in others (TX, FL, PA).

The bigger challenge isn’t can you prescribe—it’s how do you find patients without spending thousands on marketing?

That’s where a platform like Klarity makes sense. Instead of gambling on SEO or Google Ads, you get pre-qualified patients matched to your expertise—and you only pay when they book.

Ready to grow your telehealth practice? Join Klarity’s provider network and start seeing depression patients in your state—on your schedule, with no upfront marketing costs.

Citations and Sources

1. HHS Press Release – ‘HHS & DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026’ (January 2, 2026). Available at: www.hhs.gov

2. DEA Press Release – ‘DEA Announces Three New Telemedicine Rules to Continue Open Access’ (January 16, 2025). Available at: www.dea.gov

3. Florida Statutes §456.47 – ‘Use of Telehealth to Provide Services.’ Available at: www.leg.state.fl.us

4. Texas Administrative Code Title 22, Part 9 §174.5 – ‘Telemedicine Issuance of Prescriptions.’ Available at: txrules.elaws.us

5. California Board of Registered Nursing – ‘AB 890 Implementation’ (Updated January 2023). Available at: www.rn.ca.gov

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=announced%20a%20fourth%20temporary%20extension,disruptions%20in%20care%20while%20permanent
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=registration%20is%20available%20to%20medical,V%20medications
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=These%20rules%20are%20a%20result,temporary%20rule%20until%20December%202025
• https://www.dea.gov/press-releases/2025/01/16/dea-announces-three-new-telemedicine-rules-continue-open-access#:~:text=is%20accessible%20for%20medical%20care,is%20being%20prescribed%20controlled%20medication
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%20law%20previously%20allowed,based%20on%20only
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,person%20setting
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,be
• https://www.leg.state.fl.us/statutes/index.cfm?Appmode=DisplayStatute&URL=0400-0499%2F0456%2FSections%2F0456.47.html#:~:text=telehealth%20to%20provide%20health%20care,in%20Schedule%20II%20of%20s
• https://txrules.elaws.us/rule/title22chapter174sec.174.5#:~:text=,through%20a%20telemedicine%20medical%20service